Allergy Therapeutics

Allergy Therapeutics plc is a UK-based specialized pharmaceutical company developing therapeutics to treat and prevent allergies. It was formed in June 1998, through a management buy-out of the Bencard allergy vaccine business of SmithKline Beecham.At the time of its formation, Allergy Therapeutics already marketed an established range of specific immunotherapy diagnostics and therapies, including its range of Pollinex allergy desensitizing vaccines, under the brand name Bencard. The vaccines, produced in the manufacturing facility in Worthing, UK were sold through Allergy Therapeutics' sales force in Germany, Spain, Italy, Poland and Canada and through licensees in other European and Asian countries. The company's R&D activities were located in the UK and Germany.By February 2006, Allergy Therapeutics had developed and launched OralVac, a sublingual vaccine comprised of a specific mix of allergens, tailored to suit individual patients. The vaccine was available in several European countries, on